Industrial Microbiology Market

Global Industrial Microbiology Market Size

The global industrial microbiology market was valued at USD 15.18 billion in 2025, is estimated to reach USD 16.03 billion in 2026, and is projected to reach USD 24.85 billion by 2034, growing at a CAGR of 5.63% from 2026 to 2034.

Industrial microbiology is the study of biotechnology as it refers to the study of microorganisms and is used in the production of industrial items in bulk, some of which are occasionally produced using microbial cell factories. It is possible to increase maximum product yields in a variety of ways. It has several uses in the forestry, food, beverage, cosmetic, and pharmaceutical sectors. The consumer market is expanding considerably due to the expanding world population. Methods for confirming the quality of items are therefore becoming more and more necessary. Industrial microbiology encompasses all areas of upkeep, improvement, and screening of bacteria for reducing specified industrial use goods. Industrial microbiology consists of incubators and culture instruments, air control systems, microbial detection systems, filtration purposes and devices, equipment, and systems. Syrup, bioremediation, the creation of empty capsules, and genetically engineered food items are all produced using industrial microbes.

MARKET DRIVERS

Rising demand for microbiological testing and quality assurance across a number of sectors is projected to be the primary drivers of market development. The evolution of industrial microbiology has been influenced by the growth of applied microbiology. whereby microorganisms' knowledge is used to make high-yield industrial goods.

Microbiological testing techniques are now being used in a wide range of businesses as product quality requirements grow increasingly significant. For instance, STEMart introduced thorough sterility and microbiological testing services for sterile, non-pyrogenic items in June 2022.

In order to ensure the quality and integrity of the products, advanced testing is becoming more and more vital as fermented food and nutraceutical products gain popularity globally and play a significant part in food security. The growing popularity of these testing techniques in the food and beverage sector is predicted to drive growth in the global industrial microbiology market during the forecasted period. However, it is projected that demand will rise in the coming years as a result of the increased focus on industrial safety, food safety, and cleanliness. The primary factor propelling the growth of the worldwide market is the rising acceptance of process automation over traditional techniques, which will significantly lower manufacturing costs.

It is predicted that opportunities for increased influenza vaccine manufacturing will have a significant favourable effect on vaccine producers. It is also projected that the use of innovative techniques to comprehend the patterns of infectious illnesses would promote market growth. It is projected that market participants would take more strategic actions, accelerating product innovation and broadening their geographical reach.

MARKET RESTRAINTS

Factors predicted to hamper the industrial microbiology market's growth over the course of the forecast period are conflicts over the use of genetically modified organisms in food sources and an increase in product recalls. Longer product development and release cycles could potentially impede market expansion. The development of the global industrial microbiology market is anticipated to be constrained by the high costs associated with maintaining aseptic processes and producing sterile items. Before packaging microbially generated end goods, such as pharmaceutical excipients and intermediates, sterilisation is required. The increased possibility of contamination is the primary reason for this. The cost of preserving sterile conditions is substantial, though.

REPORT COVERAGE

SEGMENT ANALYSIS

By Product Insights

By product, the reaction consumables market generates the most revenue., This segment will account for more than 55% of all sales in 2022. Industrial microbiology testing requires consumables that are both irreplaceable and frequently used. The category saw exceptionally high demand during COVID-19, seriously affecting the supply chain. In order to decrease their dependency on imports, several areas urged the participants to enhance the domestic production of commodities. This shows the high demand for reaction consumable goods.

Owing to its exponential growth, the equipment and system category has had the fastest expansion, enabling them to maintain resource synergy and raise profitability. The transaction is expected to provide IDEXX access to automated instrumentation. As a result, it is projected that there will be a rise in the need for instruments and equipment due to the rising usage of industrial microbiology testing in a number of applications.

By Test Insights

By test, sterility testing to acquire the largest market share due to the growing significance of sterility testing in the production of biopharmaceuticals. The sterility test is used on medical items, medications, and preparations to be sterility and assure compliance with the rules. Aside from that, the sterility test must be passed by all parts and raw materials used to make drugs. As a result, the utilisation of sterility testing in pharmaceutical and biopharmaceutical applications is directly correlated with the volume of drug manufacture.

Microbial testing is the second most used test by Industrial microbiology for evaluating raw materials. Guidelines for the use of microbiological limits testing in the nutraceutical and cosmetic sectors have also been published by the International Organisation for Standardisation (ISO). Thus, it is anticipated that increased governmental oversight and examination of the cosmetics industry's quality and efficacy will aid in the market's expansion.

By End-User Insights

By end-users, the pharmaceutical biotechnology industry generated a sizable amount of revenue in 2024. At all phases of manufacturing, quality control must be maintained in the biotechnology and pharmaceutical sectors. The environmental monitoring technique, which assesses the quality and sterility of the controlled production environment, is one way to sustain these standards.

During the forecasted time, it is also expected that the food and beverage business would expand dramatically. End-users largely rely on industrial microbiology testing procedures to ensure that any harmful poisons and diseases are removed from the goods and safeguard customers from consuming germs.

REGIONAL ANALYSIS

By region, North America is to hold the largest market share. Due to the region's thriving biotechnology and pharmaceutical sectors, North America holds a share of around 48%. The rise of the regional market is expected to be greatly accelerated by the expanding research and development activities in the biopharmaceutical industry and initiatives to identify novel medicines.

Asia Pacific is anticipated to see exponential expansion in the next years as a result of the region's expanding need for industrial microbiology. The pharmaceutical industry's rising R&D endeavours and drug development techniques will help the local market grow. For instance, Merck India stated in June 2022 that a Microbiology Application Training Lab (MAT Lab) will be established in Bangalore for both academic and commercial objectives. The Lab invites Merck and other pharma and biopharma companies to work together to build up their skills for microbial investigation.

Europe’s market held a sizeable portion of the overall industry and is anticipated to expand significantly over the years. In the anticipated years, the rest of the world is expected to grow at a considerable CAGR.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global Industrial microbiology market include

• BioMérieux SA
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company (BD)
• QIAGEN N.V.
• Danaher Corporation
• Merck KGaA
• Asiagel Corporation
• Eppendorf AG
• Novamed
• Sartorius AG

GLOBAL INDUSTRIAL MICROBIOLOGY MARKET NEWS

• In April 2022, Adaptive Phage Therapeutics (APT) and Venatorx Pharmaceuticals both received funding from the Antimicrobial (AMR) Action Fund. The transactions are the Fund's first investments, and they represent a significant step toward the Fund's goal of bringing novel therapies to market for priority pathogens defined by the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC).
• In April 2022, Hygiena launched a new, ultra-rapid, microbial screening kit, RapiScreen Beverage Kit, that provides high-performance testing for low pH beverages using Innovate System. The kit provides quality control results in less than 30 minutes following a preliminary incubation period, allowing manufacturers to confirm product quality for quick release to market.

MARKET SEGMENTATION

The market of Industrial microbiology is segmented and sub-segmented into product, test, end-user & region.

By Product

• Equipment and Systems
  • Filtration Pumps and Systems
  • Microbial Detection Systems
  • Air Monitoring Systems
  • Automated Equipment
  • Incubators and Culture Apparatus
  • Others
• Reaction Consumables
  • Media
  • Reagents and Strains
• Laboratory Supplies
  • Bags and Bottles
  • Loop and Needles
  • Petri Dishes, Racks, Seals, Plates, and Holders
  • Filtration Disc and Membranes
  • Others

By Test

• Sterility Testing
• Microbial Limits Testing
• Bio-burden Testing
• Water and Environmental Testing

By End-User

• Food and Beverages
• Pharmaceutical Biotechnology
• Agricultural
• Environmental
• Cosmetic and Personal Care
• Others

By Region

• North America
• Europe
• Asia-Pacific
• The Middle East & Africa
• Latin America